These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31301562)

  • 21. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antioxidant and Aβ anti-aggregation properties of new ferulic, caffeic and lipoic acid derivatives obtained by the Ugi four-component reaction.
    Benchekroun M; Pachón-Angona I; Luzet V; Martin H; Oset-Gasque MJ; Marco-Contelles J; Ismaili L
    Bioorg Chem; 2019 Apr; 85():221-228. PubMed ID: 30640071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease.
    Zhang X; He X; Chen Q; Lu J; Rapposelli S; Pi R
    Bioorg Med Chem; 2018 Feb; 26(3):543-550. PubMed ID: 29310862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
    Danysz W; Parsons CG
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer's disease agents.
    Yang GX; Huang Y; Zheng LL; Zhang L; Su L; Wu YH; Li J; Zhou LC; Huang J; Tang Y; Wang R; Ma L
    Eur J Med Chem; 2020 Feb; 187():111913. PubMed ID: 31837501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.
    Gazova Z; Soukup O; Sepsova V; Siposova K; Drtinova L; Jost P; Spilovska K; Korabecny J; Nepovimova E; Fedunova D; Horak M; Kaniakova M; Wang ZJ; Hamouda AK; Kuca K
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):607-619. PubMed ID: 27865910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking.
    Ito K; Tatebe T; Suzuki K; Hirayama T; Hayakawa M; Kubo H; Tomita T; Makino M
    Eur J Pharmacol; 2017 Mar; 798():16-25. PubMed ID: 28167259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
    Bordji K; Becerril-Ortega J; Buisson A
    Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.
    Harkany T; Hortobágyi T; Sasvári M; Kónya C; Penke B; Luiten PG; Nyakas C
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):963-1008. PubMed ID: 10621945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ
    Liu Y; Zhang P; Zheng Y; Yang C; Du T; Ge M; Chang X; Duan R; Ma G
    Neurochem Res; 2018 Oct; 43(10):2008-2015. PubMed ID: 30155805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro.
    Mitchell RM; Neafsey EJ; Collins MA
    J Neurochem; 2009 Oct; 111(2):580-8. PubMed ID: 19694907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of
    Park JS; Kim T; Kim D; Jeong YI
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classics in Chemical Neuroscience: Memantine.
    Alam S; Lingenfelter KS; Bender AM; Lindsley CW
    ACS Chem Neurosci; 2017 Sep; 8(9):1823-1829. PubMed ID: 28737885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.
    Hu NW; Klyubin I; Anwyl R; Rowan MJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20504-9. PubMed ID: 19918059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine, a Low-Affinity NMDA Receptor Antagonist, Protects against Methylmercury-Induced Cytotoxicity of Rat Primary Cultured Cortical Neurons, Involvement of Ca
    Liu W; Xu Z; Yang T; Xu B; Deng Y; Feng S
    Mol Neurobiol; 2017 Sep; 54(7):5034-5050. PubMed ID: 27538940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease.
    He F; Ran Y; Li X; Wang D; Zhang Q; Lv J; Yu C; Qu Y; Zhang X; Xu A; Wei C; Chou CJ; Wu J
    Bioorg Chem; 2020 Oct; 103():104109. PubMed ID: 32768741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.